Form 8-K - Current report:
SEC Accession No. 0001655759-25-000147
Filing Date
2025-09-17
Accepted
2025-09-17 16:32:51
Documents
19
Period of Report
2025-09-17
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20250917.htm   iXBRL 8-K 40685
2 EX-99.1 arvnstrategicupdaterelea.htm EX-99.1 18174
6 arvnstrategicupdaterelea001.jpg GRAPHIC 223740
7 arvnstrategicupdaterelea002.jpg GRAPHIC 270251
8 arvnstrategicupdaterelea003.jpg GRAPHIC 240382
9 arvnstrategicupdaterelea004.jpg GRAPHIC 291497
10 arvnstrategicupdaterelea005.jpg GRAPHIC 282708
11 arvnstrategicupdaterelea006.jpg GRAPHIC 33308
  Complete submission text file 0001655759-25-000147.txt   2040221

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20250917.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20250917_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20250917_pre.xml EX-101.PRE 13581
21 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20250917_htm.xml XML 2816
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 251320464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)